Raúl de la Flor

Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR

Anne-Cécile Fricker, M. H. Selina Mok, Raúl de la Flor et al. · Neuropharmacology · 2009 · 74 citations

Biochemistry, Medicine, Neuropharmacology +4

In Vitro and In Vivo Characterization of the Non-peptide NK3 Receptor Antagonist SB-223412 (Talnetant): Potential Therapeutic Utility in the Treatment of Schizophrenia

Lee A. Dawson, Katherine J Cato, Claire M. Scott et al. · Neuropsychopharmacology · 2007 · 43 citations · Full text

Psychiatry, Medicine, Immunology +9

Pharmacokinetics and Pharmacodynamics of the Nitroimidazole DNDI-0690 in Mouse Models of Cutaneous Leishmaniasis

Gert-Jan Wijnant, Simon L. Croft, Raúl de la Flor et al. · Antimicrobial Agents and Chemotherapy · 2019 · 39 citations · Full text

Development and application of a liquid chromatography/tandem mass spectrometric assay for measurement of N-acetylaspartate, N-acetylaspartylglutamate and glutamate in brain slice superfusates and tissue extracts

Ajit J. Shah, Raúl de la Flor, A.R. Atkins et al. · Journal of Chromatography B · 2008 · 23 citations

Brain Slice Superfusates, Medicine, Bioanalysis +13

In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics

Lee A. Dawson, Christopher J. Langmead, Adeshola Dada et al. · European Journal of Pharmacology · 2009 · 13 citations

Enhanced Brain Penetration, Medicine, Neuropeptide Receptor +10